Epstein-Barr Virus in Human Malignancy: A Special Reference to Epstein-Barr Virus Associated Gastric Carcinoma

키워드

참고문헌 (96)

1. "Sarcoma involving the jaws in Africa children", pp.218~23 (1958)
2. "Virus particles in cultured lymphoblasts from Burkitt's lymphoma", pp.702~3 (1964)
3. "Relation of Burkitt's tumor- associated herpes-type virus to infectious mononucleosis", pp.94~101 (1968)
4. "International Agency for Research on Cancer", 70 (1997)
5. "The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA", pp.25~9 (1987)
6. "Epstein-Barr viral DNA in tissues of Hodgkin's disease", pp.86~91 (1987)
7. "T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections", pp.733~741 (1988)
8. "Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction", pp.377~80 (1990)
9. "Detection of Epstein-Barr virus in invasive breast cancers", pp.1376~81 (1990)
10. "Epstein- Barr virus in epithelial cell tumors", pp.39~45 (1995)
11. "Detection of Epstein-Barr virus a novel EBV" (1999)
12. "Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley P, eds. Fields virology", pp.2511~73 (2001)
13. "Gammaherpesviruses and “Hit-and-Run", pp.1~3 (2000)
14. "Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells no evidence for the persistence of integrated viral fragments in Latent membrane protein-1", pp.209~1 16 (2000)
15. "DNA sequence and expression of the B95-8 Epstein-Barr virus genome", pp.207~11 (1984)
16. "The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation", pp.883~9 (1986)
17. "The Switch between latency and replication of Epstein-Barr virus", pp.833~44 (1990)
18. "Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus to the EBV", C3d receptor of B cells sequence homology of gp350 and C3 complement fragment C3d, 1987, 1416~20
19. "Alternate replication in B cells and epithelial ells switches tropism of Epstein-Barr virus", pp.594~9 (2002)
20. "Epstein-Barr virus replication in oropharyngeal epithelial cells", pp.1225~30 (1984)
21. "Clinical syndromes associated with EB virus infections", pp.77~93
22. "Epstein-Barr virus infection and immunoregulation in man", pp.99~149
23. "Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones consititutive and inducible expression of interleukin-4 mRNA", eur j immu(l), pp.897~903 (1993)
24. "Epstein-Barr virus BARF1 protein is dispensable for B-cell", pp.7627~32 (1999)
25. "Inhibition of ubiquitin", proteosome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1, 1997, 12616~21
26. "Epstein-Barr virus oncogenesis and the ubiquitin- proteasome system", pp.2107~15 (2004)
27. "An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells", pp.831~40 (1985)
28. "Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus", pp.447~9 (1990)
29. "Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice", pp.11963~8 (1998)
30. "Epstein-Barr virus encoded latent membrane protein-1 induces", pp.6730~8 (2001)
31. "The Epstein-Barr virus and its association with human cancers", constandi(u c), pp.307~22 (1999)
32. "In situ hybridization of Epstein-Barr virus in tumor cells and tumor-infiltrating lymphocytes of the gastrointestinal tract", pp.297~301 (2001)
33. "Epstein-Barr virus in gastric carcinomas with lymphoid stroma", pp.309~15 (2000)
34. "Detection of EBV gene expression in Reed- Sternberyg cells of Hodgkin’s disease", pp.801~4 (1990)
35. "Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection", pp.105~9 (1993)
36. "Microsatellite instability and Epstein-Barr virus", pp.486~92 (2000)
37. "Clinicopathologic characteristics of Epstein-Barr virus-incorporated", pp.395~400 (2001)
38. "p53 protein and microsatellite instability in adenoma-carcinoma sequence of the stomach", pp.415~20 (2002)
39. "Epstein-Barr virus and microsatellite instability in gastric carcinogenesis", pp.447~52 (2003)
40. "bcl-2 and NF-kB in Epstein-Barr virus-associated gastric carcinomas"
41. "In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in", pp.44~7 (1996)
42. "Headquarters of Korea Central Cancer Registry Cancer Registry system in Korea"
43. "Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach", pp.73~81 (1994)
44. "Epstein-Barr virus infection in non-carcinomatous", pp.293~8 (1997)
45. "Epstein- Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2", pp.20~7 (1996)
46. "Elevated antibody titers to Epstein- Barr virus prior to the diagnosis of Epstenin-Barr", pp.642~4 (1995)
47. "Epstein-Barr virus and gastric carcinoma.", pp.175~82 (1996)
48. "rare association of the virus with gastric adenocarcinomas", pp.1014~9 (1993)
49. "Epstein-Barr virus in gastric carcinoma", pp.1250~4 (1993)
50. "Epstein-Barr virus- associated gastric adenocarcinomas among Koreans", pp.174~81 (1996)
51. "Epstein-Barr virus in gastric carcinoma with lymphoid stroma Special Reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors", pp.2239~49 (1994), including a morphological analysis
52. "Characteristics of Epstein-Barr virus- associated gastric carcinoma with lymphoid stroma in Japan", mastsu(u h) (1996)
53. "Gastric carcinoma with lymphoid stroma", pp.232~43 (1976)
54. "Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma", take nu(uchi t mura m), pp.1063~71 (1993)
55. "Morphological characterics of Epstein-Barr virus-related early gastric carcinoma", pp.360~7 (1997)
56. "Epstein- barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison to epstein-barr virus- negative carcinoma", pp.1698~705 (2004)
57. "Evidence of lytic infection of Epstein-Barr virus", pp.351~9 (2002)
58. "Expression of Epstein-Barr virus genes in EBV- associated gastric carcinomas", pp.~33 (2005)
59. "A transforming function of the BARF1 gene encoded by Epstein-Barr virus", pp.2897~903 (1989)
60. "N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is-2", pp.1176~85 (2001)
61. "Malignant transformation of Epstein-Barr virus-negative Akata cells", pp.3859~65 (2003)
62. "Unique transcription pattern of Epstein-Barr virus expression of the transforming BARF1 gene", pp.2745~8 (2000)
63. "Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2", pp.4510~4 (1984)
64. "Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism", pp.1578~80
65. "Loss of p16", CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach, 2000, 45~50
66. "Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcino", pp.787~94 (2002)
67. "Microsatellite instability in the progression of gastric carcinoma", pp.4595~7 (1994)
68. "mutation of type II transforming growth factor receptor and BAX in gastric carcinomas in Hong Kong Chinese", pp.582~8 (1999)
69. "Relation to H", pp.1031~8 (2000)
70. "regulatory protein ICP0 interacts with and Ubiquitinates p53", pp.36596~1 602 (2003)
71. "Arrowsmith C, Frappier", pp.47753~61 (2003)
72. "Antisense strategies and therapeutic applications", pp.151~60 (1996)
73. "Potent and specific inhibition of human immunodeficiency virus type 1", pp.9225~31 (2002)
74. "Selective silencing of viral gene expression in HPV-positive human cervical", pp.6041~8 (2002)
75. "NFkB inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells", pp.6055~60 (2000)
76. "Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide", pp.4625~30 (2004)
77. "Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype", pp.1194~201 (1998)
78. "Replication from oriP of Epstein-Barr virus requires", pp.287~96 (2001)
79. "Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis but lytic gene", pp.2400~10 (2001)
80. "Activation of lytic Epstein-Barr virus infection by radiation and sodium butyrate in vitro and in vivo", pp.5781~8 (2000)
81. "Synergistic anticancer effects of ganciclovir", thymidine kinase and 5-fluorocytosine, pp.1998[DOI]
82. "Switching viral latency to viral lysis A novel therapeutic approach for Epstein-Barr", pp.969~72 (1996)
83. "Demethylation of the Epstein-Barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent", pp.2219~2 (1999)
84. "MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1", pp.141~6 (2002)
85. "Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines", pp.131~5 (1981)
86. "Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr", pp.1549~55 (1998)
87. "Epstein-Barr nuclear antigen 1-specific", j immu(l), pp.1593~603 (2002)
88. "Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related", pp.9~13 (1995)
89. "Identification of target antigens for the human Kieff E Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus impli cations for the immune control of EBV-positive malignancies", pp.157~68 (1992)
90. "Adoptive transfer of autologous Epstein-Barr virus- specific cytotoxic T cells for nasopharyngeal carcinoma", pp.73~80 (2001)
91. "Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies influence of recombinant IL12 and IL15", pp.231~40 (2003)
92. "Dual stimulation of Epstein-Barr virus -specific CD4+", - and CD8 +, pp.2004[DOI]
93. "Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity", pp.3179~87 (2002)
94. "In vitro T cell responses to a candidate Epstein-Barr virus vaccine human CD4+ T gp340", eur j immu(l), pp.1689~97 (1998)
95. "DNA-mediated immunization of glycoprotein 350 of Epstein-Barr the antigen", pp.41~9 (2001)
96. "as targets for ex vivo virus-specific CTL during acute infectious", j immu(l), pp.3063~9 (1999)

관련 논문AI추천